This document provides instructions for performing a phagocytic engulfment test and interpreting its results. The test involves incubating a mixture of bacteria and phagocytes to examine for the presence of engulfed bacteria. A positive result demonstrates the engulfment of bacteria and supports impaired neutrophil function. The test has limitations as a screening procedure and false negatives can occur if the blood sample is not fresh or the wrong bacteria are used. Proper handling procedures and controls are required when performing the assessment.
This document provides instructions for performing a phagocytic engulfment test and interpreting its results. The test involves incubating a mixture of bacteria and phagocytes to examine for the presence of engulfed bacteria. A positive result demonstrates the engulfment of bacteria and supports impaired neutrophil function. The test has limitations as a screening procedure and false negatives can occur if the blood sample is not fresh or the wrong bacteria are used. Proper handling procedures and controls are required when performing the assessment.
This document provides instructions for performing a phagocytic engulfment test and interpreting its results. The test involves incubating a mixture of bacteria and phagocytes to examine for the presence of engulfed bacteria. A positive result demonstrates the engulfment of bacteria and supports impaired neutrophil function. The test has limitations as a screening procedure and false negatives can occur if the blood sample is not fresh or the wrong bacteria are used. Proper handling procedures and controls are required when performing the assessment.
This document provides instructions for performing a phagocytic engulfment test and interpreting its results. The test involves incubating a mixture of bacteria and phagocytes to examine for the presence of engulfed bacteria. A positive result demonstrates the engulfment of bacteria and supports impaired neutrophil function. The test has limitations as a screening procedure and false negatives can occur if the blood sample is not fresh or the wrong bacteria are used. Proper handling procedures and controls are required when performing the assessment.
stain. PRE-ANALYTICAL PHASE: The site of the experiment should be sterilized. The Wright’s Stain Procedure: medical technologist should wear proper personal protective equipment before the experiment A. Cover each smear generously with filtered (laboratory gown, laboratory goggles or face-shield, Wright’s stain and allow the stain to remain on laboratory mask, and gloves) the slide for at least 5 minutes. B. Slowly add distilled water or buffer to the stain No special preparation of the patient is required until the buffer begins to overflow the stain. before specimen collection. Blood should be drawn Watch for the appearance of a metallic luster. by an aseptic technique. A minimum of 2 ml of C. Gently blow on the slide to mix the stain and heparin blood (green-top evacuated tube) or 15 to buffer. 20 heparinized capillary tubes are required. The D. Allow the buffer to remain on the slide for at specimen should be centrifuged, and the test should be least 5 minutes. performed promptly. For the quality control, a fresh, E. Gently wash the stain and buffer off the slide heparinized sample of blood from a healthy volunteer with distilled water. should be tested simultaneously. F. Air dry or carefully blot the slide between two The microscope should be placed on a plain, stable sheets of bibulous paper surface. The voltage of the power supply should be inclined with that of the equipment. Proper handling 7. Place a drop of immersion on each smear and and cleanliness of compound microscope should be examine microscopically with the oil (100x) observed at all times by the medical technologist. Lens immersion objective. paper is provided in order to clean the objective and ocular lenses. POST-ANALYTICAL PHASE: All infectious materials should be disposed ANALYTICAL PHASE: appropriately. The working area should be cleansed with the disinfectant before leaving. The PPE of each Materials individual should be removed properly. These cannot - Broth culture of Bacillus subtilis or be exposed outside the laboratory premises. Staphylococcus epidermidis o 0 mins o 15 mins Interpretation of Results o 30 mins POSITIVE - Demonstration of the engulfment of - Microscope slides bacteria - Pasteur pipettes NEGATIVE - No engulfment of bacteria - Rubber bulb - Test tubes - Wright’s stain INTRODUCTION Procedure: Phagocytosis 1. Label three test tubes: Patient test tube and Control test tube - Process by which specialized cells engulf and 2. Add 4 to 8 drops of the buffer coat from either destroy foreign particles such as the patient’s heparinized blood or from the microorganisms or damaged cells. normal control to the respectively labeled - Macrophages and neutrophils (pmns) are tubes. the most important phagocytic cells 3. Add 2 to 3 drops of the bacterial broth culture to each tube. A mixture of bacteria and phagocytes is incubated and 4. Incubate both tubes at room temperature and examined for the presence of engulfed bacteria. This 37 C for 30 minutes. simple procedure may be useful in supporting the 5. Place 1 drop of the incubated specimen on a diagnosis of impaired neutrophilic function in glass slide and prepare a smear. conjunction with clinical signs and symptoms with anti-human CRP in a stabilized buffer with less than 0.1% sodium Sources of error azide as preservative CRP Positive Control: Human serum that This procedure may produce false-negative results if contains more than the blood specimen is not fresh or if a coagulase 6mg/L CRP and less positive Staphylococcus specimen is used. It is than 0.1% sodium azide important to distinguish between granules and cocci. In as preservative Addition, the bacteria must be intracellular and not CRP Negative Control: Human serum that has extracellular for the test to be positive been diluted and stabilized with buffer Clinical Applications and contain less than 0.1% sodium azide as The failure of phagocytes to engulf bacteria can preservative support the diagnosis of neutrophilic dysfunction; Glycine-saline To be diluted 1:20 with however, these results must be used in conjunction Buffer: distilled water with patient signs and symptoms (20X) Concentrate Limitations of this Procedure Disposable pipettes and test slides This is the simple screening procedure for engulfment. III. Results The presence of engulf bacteria does not demonstrate that the bacteria have been destroyed - Positive Result: Agglutination - Negative Result: Smooth milky suspension - Since negative results may be caused by C-REACTIVE PROTEIN DETERMINATION antigen excess, the test should be repeated C-reactive Protein – acute phase or reactants on using a diluted serum sample in case prozone which its concentration or its levels on your serum effect is suspected increases during inflammation IV. Clinical Significance - Non- specific marker of inflammation - Increase when you have a fever, TB, viral C-reactive protein (CRP) infections, bacterial infections - a trace constituent of serum originally Reagents must be brought to room temperature thought to be an antibody to the and must be shaken well before dispensing. Polysaccharide of pneumococci Undiluted serum will be used to react with the CRP - It was discovered by Tillet and Francis in latex reagent. 1930 when they observed that serum from patients with Streptococcus pneumoniae infection precipitated with a soluble extract LABORATORY DISCUSSION GUIDE: of the bacteria. - Now CRP is known to have a more I. Principle of the test generalized role in innate immunity. - Reverse Passive Agglutination. It is based on - CRP can be thought of as a primitive, the latex- agglutination method. The principle nonspecific form of an antibody molecule of this test is based on the immunological that is able to act as a defense against reaction between CRP as an antigen and the microorganisms or foreign cells until specific corresponding antibody coated on the surface antibodies can be produced of biologically inert latex particles II. Reagents of the test CRP is a relatively stable serum protein with a half- life of about 18 hours. 1 It increases rapidly within 4 to 6 hours following infection, surgery, or other trauma MATERIALS AND COMPONENTS to the body. Levels increase dramatically as much as a Materials provided with the test kits hundredfold to a thousand-fold, reaching a peak value within 48 hours. Elevated levels are found in CRP Latex Reagent: Contains polystyrene conditions such as bacterial infections, rheumatic latex particles coated fever, viral infections, malignant diseases, tuberculosis, and after a heart attack. The median CRP one drop of CRP Latex to each circle that value for an individual increases with age, reflecting contains specimens on the slide. Spread the an increase in subclinical inflammatory conditions resulting mixture by using the paddle end of the pipette. Do not use the same paddle end to Because the levels rise and then decline so rapidly, mix each test serum or control as this will CRP is the most widely used indicator of acute cause cross- contamination. inflammation. Although CRP is a nonspecific indicator 5. Gently tilt and rotate slide by hand for two (2) of disease or trauma, monitoring of its levels can be minutes. useful clinically to follow a disease process and 6. Observe for macroscopic clumping using the observe the response to treatment of inflammation and indirect oblique light source. infection 7. Compare the reaction of the test serum to the It is a nonsurgical means of following the course of CRP positive and negative control sera malignancy and organ transplantation because a rise in the level may mean a return of the malignancy or, in the case of transplantation, the beginning of organ Method II (Semi-Quantitative) rejection. CRP levels can also be used to monitor the 1. For each test serum to be titrated, set up a least progression or remission of autoimmune diseases. 6 test tubes (12 x 75 mm) and label 1:2, 1:4, Assays for CRP are sensitive, reproducible, and 1:8, 1:16, 1:32, 1:64, etc. relatively inexpensive. CRP is easily destroyed by 2. To each tube add 0.2 ml of Diluted Glycine- heating serum to 56°C for 30 minutes. The destruction Saline Buffer. of CRP is often necessary in the laboratory because it 3. To Tube No. 1 add 0.2 ml of undiluted test interferes with some testing for the presence of serum antibodies 4. Serially make two-fold dilutions by mixing The Centers for Disease Control and Prevention contents of Tube No. 1 with pipette and (CDC) has recommended that a CRP concentration of transferring 0.2 ml to Tube No. 2. Repeat less than 1 mg/L is associated with a low risk for serial transfers for each tube. For the 6 tubes, cardiovascular disease; 1 to 3 mg/L is associated with the dilutions range from 1:2 to 1:64. If an average risk; and greater than 3 mg/L is associated required, additional serum dilutions can be with a high risk. Normal levels in adults range from added. approximately 0.47 to 1.34 mg/L. A mean for people 5. Repeat steps 3 to 7 as given in Method I with no coronary artery disease is 0.87 mg/L. Thus, (Qualitative) monitoring CRP may be an important preventative measure in determining the potential risk of heart PRECAUTIONS attack or stroke. High-sensitivity CRP testing has the necessary lower level of detection of 0.01 mg/L, which This product is for In Vitro Diagnostic Use Only. Each enables measurement of much smaller increases than donor unit used in the preparation of this product has the traditional latex agglutination screening test been tested by an FDA approved method and found non-reactive for the presence of HbsAg and antibody V. And other important information in the test to HIV Virus. Because no known test method can offer insert complete assurance that hepatitis B virus, HIV Virus, Method I (Qualitative) or other infectious agents are absent, all human blood based products should be handled in accordance with 1. Bring all test reagents and serum specimens to good laboratory practices. The preservative sodium room temperature. azide may react with metal plumbing to form explosive 2. Gently shake the CRP latex vial to disperse metal oxides. In disposal, flush with a large volume of and suspend latex particles. water to prevent metal azide build up 3. Positive and negative controls should be tested with each series of test. STORAGE & STABILITY 4. Using the disposable pipette provided, place When not in use, store reagents and controls at 2 - 8 one drop of test serum onto a circle on the degree Celsius. DO NOT FREEZE. Prior to use, allow slide. Use a separate disposable pipette for reagents and controls to warm up to room temperature. each test serum. Important: The Cortez CRP Expiration date is specified on the kit label and on each Latex Reagent must be agitated well for about vial. Biological indication of product instability is 10 seconds prior to using on each day’s evidenced by inappropriate reaction of the latex testing. Do not use a vortex mixer. Deliver reagent with the corresponding positive and negative control sera